Efficacy and safety of tirofiban bridge as an alternative to suspension of dual antiplatelet therapy in patients undergoing surgery: a systematic review

Use of a tirofiban bridge is an alternative to simply withdrawing dual antiplatelet therapy prior to operating on patients at high risk of stent thrombosis and bleeding. We aimed to evaluate the efficacy and safety of this protocol in patients undergoing surgery within 12 months of a percutaneous co...

Descripción completa

Detalles Bibliográficos
Autores principales: Riscado, Lorrane Vieira Siqueira, de Pinho, João Henrique Sendrete, Lobato, Armando de Carvalho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Angiologia e de Cirurgia Vascular (SBACV) 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668084/
https://www.ncbi.nlm.nih.gov/pubmed/34925474
http://dx.doi.org/10.1590/1677-5449.210113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668084/
https://www.ncbi.nlm.nih.gov/pubmed/34925474
http://dx.doi.org/10.1590/1677-5449.210113

Ejemplares similares